MAPK3 and hepatocellular carcinoma: Correspondingly, BBP, inhibiting GJIC and activating MAPK-Erk1/2 in our study, was previously found to induce invasion, migration, and the angiogenesis of hepatocellular carcinoma cells Huh7 via rapid non-genomic aryl hydrocarbon receptor/G-protein dependent mechanism [70].